| Tracey J Swan, | |
|
102 Woodchase Park Dr, Clinton, MS 39056-4113 | |
| (601) 924-7043 | |
| (601) 924-8633 |
| Full Name | Tracey J Swan |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 102 Woodchase Park Dr, Clinton, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083939342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT0153 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tracey J Swan, 102 Woodchase Park Dr, Clinton, MS 39056-4113 Ph: (601) 924-7043 | Tracey J Swan, 102 Woodchase Park Dr, Clinton, MS 39056-4113 Ph: (601) 924-7043 |
News Archive
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
One of the fastest translations of a basic research discovery into a promising clinical trial for an "untreatable" and fatal disorder will be discussed publicly for the first time by the key players in this remarkable research story, on Sunday, Dec. 14, at the American Society for Cell Biology (ASCB)'s annual meeting in San Francisco.
Exposure to air pollution at the place of residence increases the risk of developing insulin resistance as a pre-diabetic state of type 2 diabetes.
An inexpensive, FDA-approved drug - cholestyramine - taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.
› Verified 4 days ago
Karlyn Bren Goff, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 Morrison Dr, Clinton, MS 39056 Phone: 662-207-1090 Fax: 601-510-9861 | |
Kathryn Cassady, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 902 Live Oak Dr, Clinton, MS 39056 Phone: 601-951-1522 | |
Nancy Ann Bailey, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 Caroline Cv, Clinton, MS 39056 Phone: 601-925-5204 | |
Mrs. Rhea Mccann Estes, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 409 Patio Pl, Clinton, MS 39056 Phone: 601-813-3863 | |
Mr. Scott Bowman Garrett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 E Northside Dr, Clinton, MS 39056 Phone: 601-926-1224 | |
Jennifer J Bird, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 E Northside Dr, Clinton, MS 39056 Phone: 601-926-1224 |